Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Westerweel

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Clinical Nutrition ESPEN|September 22, 2023
Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists' experiences and perspectivesRianne van Lieshout, Lidwine W Tick, Fenne de Beer, et al.
Haematologica|September 2, 2017
Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survivalInge G P Geelen, Noortje Thielen, Jeroen J W M Janssen, et al.
British Journal of Haematology|December 5, 2021
The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population-based study in the Netherlands, 1989-2018Carolien C H M Maas, David van Klaveren, Geneviève I C G Ector, et al.
Leukemia & Lymphoma|November 6, 2020
Tyrosine kinase inhibitor treatment discontinuation in chronic myeloid leukemia: patient viewsVashti N M F Tromp, Lonneke Timmers, Leanne Koningen, et al.
European Journal of Clinical Pharmacology|June 4, 2020
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinibChristel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
CD34+ cells home, proliferate, and participate in capillary formation, and in combination with CD34- cells enhance tube formation in a 3-dimensional matrixMaarten B Rookmaaker, Marianne C Verhaar, Cindy J M Loomans, et al.
British Journal of Haematology|May 19, 2025
The 'Stop TPO-RA in ITP Patients' study: Clinical and immune modulatory effects of romiplostim taperingVivianne S Nelson, Sufia N Amini, Tanja Netelenbos, et al.
Research and Practice in Thrombosis and Haemostasis|June 18, 2020
Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrateRoisin Bavalia, Rahat Abdoellakhan, Herm Jan M Brinkman, et al.
European Journal of Haematology|September 21, 2023
BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient populationCamille Kockerols, Peter J M Valk, Nicole M A Blijlevens, et al.
British Journal of Haematology|July 12, 2020
Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort studyPaul J Hengeveld, Aaram O Khader, Linda H A de Bruin, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Clinical Nutrition ESPEN|September 22, 2023
Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists' experiences and perspectivesRianne van Lieshout, Lidwine W Tick, Fenne de Beer, et al.
Haematologica|September 2, 2017
Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survivalInge G P Geelen, Noortje Thielen, Jeroen J W M Janssen, et al.
British Journal of Haematology|December 5, 2021
The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population-based study in the Netherlands, 1989-2018Carolien C H M Maas, David van Klaveren, Geneviève I C G Ector, et al.
Leukemia & Lymphoma|November 6, 2020
Tyrosine kinase inhibitor treatment discontinuation in chronic myeloid leukemia: patient viewsVashti N M F Tromp, Lonneke Timmers, Leanne Koningen, et al.
European Journal of Clinical Pharmacology|June 4, 2020
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinibChristel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
CD34+ cells home, proliferate, and participate in capillary formation, and in combination with CD34- cells enhance tube formation in a 3-dimensional matrixMaarten B Rookmaaker, Marianne C Verhaar, Cindy J M Loomans, et al.
British Journal of Haematology|May 19, 2025
The 'Stop TPO-RA in ITP Patients' study: Clinical and immune modulatory effects of romiplostim taperingVivianne S Nelson, Sufia N Amini, Tanja Netelenbos, et al.
Research and Practice in Thrombosis and Haemostasis|June 18, 2020
Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrateRoisin Bavalia, Rahat Abdoellakhan, Herm Jan M Brinkman, et al.
European Journal of Haematology|September 21, 2023
BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient populationCamille Kockerols, Peter J M Valk, Nicole M A Blijlevens, et al.
British Journal of Haematology|July 12, 2020
Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort studyPaul J Hengeveld, Aaram O Khader, Linda H A de Bruin, et al.
Pageof 11